Advertisement
Australia markets closed
  • ALL ORDS

    7,935.70
    -99.20 (-1.23%)
     
  • AUD/USD

    0.6652
    -0.0006 (-0.09%)
     
  • ASX 200

    7,665.60
    -101.10 (-1.30%)
     
  • OIL

    80.56
    +0.73 (+0.91%)
     
  • GOLD

    2,347.40
    -9.10 (-0.39%)
     
  • Bitcoin AUD

    101,951.63
    -402.31 (-0.39%)
     
  • CMC Crypto 200

    1,459.59
    -25.10 (-1.69%)
     

The 16% return this week takes SciDev's (ASX:SDV) shareholders five-year gains to 260%

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more than 100%. One great example is SciDev Limited (ASX:SDV) which saw its share price drive 235% higher over five years. On top of that, the share price is up 61% in about a quarter.

Since the stock has added AU$11m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

View our latest analysis for SciDev

Because SciDev made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

ADVERTISEMENT

For the last half decade, SciDev can boast revenue growth at a rate of 62% per year. Even measured against other revenue-focussed companies, that's a good result. Meanwhile, its share price performance certainly reflects the strong growth, given the share price grew at 27% per year, compound, during the period. This suggests the market has well and truly recognized the progress the business has made. SciDev seems like a high growth stock - so growth investors might want to add it to their watchlist.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

Take a more thorough look at SciDev's financial health with this free report on its balance sheet.

What About The Total Shareholder Return (TSR)?

We've already covered SciDev's share price action, but we should also mention its total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. We note that SciDev's TSR, at 260% is higher than its share price return of 235%. When you consider it hasn't been paying a dividend, this data suggests shareholders have benefitted from a spin-off, or had the opportunity to acquire attractively priced shares in a discounted capital raising.

A Different Perspective

We regret to report that SciDev shareholders are down 32% for the year. Unfortunately, that's worse than the broader market decline of 2.3%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 29% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - SciDev has 1 warning sign we think you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on AU exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here